Connor, after long symbolizing personalized medicine’s failures, has come to represent its promise.

What sounds like a victory propelled by a parent’s perseverance is being overshadowed by a lesser-known but increasingly common trend: Drugmakers are shelving many of those family-funded therapies.

Francis deSouza has stepped down as CEO of Illumina, just weeks after he survived an activist investor’s campaign to remove him from the DNA sequencing giant’s board.

Zolgensma is a miracle of modern medicine, but its steep price has largely placed it out of reach in poorer countries.

Julia Vitarello's journey with grief -- and her quest to scale a first-of-its-kind medicine

Consulate's bankruptcy threats, corporate structure and paltry liability insurance left families with little chance of recourse for alleged wrongdoing.

With a proliferation in DNA testing, more people are figuring out they were “doctor conceived.”

Clinical trials for Covid-19 vaccines and treatments are speeding along. Not so much for everything else.

Now that authorized versions are available, it’s tough to recruit volunteers for trials that might give them a placebo.

Keane Hayes pursued an ocean-filled year not just to reclaim his passion, but also to inspire surfers and non-surfers to overcome formidable odds

Why paddle out under the stars? To get away from the crowds, mainly.